Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Experimental and Therapeutic Medicine|December 15, 2018
Exploration of the regulation and control mechanisms of miR-145 in trophoblast cell proliferation and invasionZhenjing Chi, Muling Zhang
Applied Microbiology and Biotechnology|October 23, 2019
Insulin and its single-chain analogueRuifeng Mao, Yingying Chen, Zhenjing Chi, et al.
The Journal of International Medical Research|June 13, 2020
Long noncoding RNA SNHG12 promotes the proliferation, migration, and invasion of trophoblast cells by regulating the epithelial-mesenchymal transition and cell cycleFenmei Zhou, Yanlan Sun, Zhenjing Chi, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 22, 2024
Circ-ADAM9 Knockdown Reduces Insulin Resistance and Placental Injury in Diabetic Mice via MAPK Pathway InactivationAi Zhao, Yawen Yang, Yijun Yang, et al.
Environmental Toxicology|February 21, 2022
Dysregulated pseudogene BNIP3P1 inhibited cell proliferation and promoted cell apoptosis in preeclampsia by acting as a competing endogenous RNA for BNIP3Haoyu Zheng, Mengna Shi, Zhenjing Chi, et al.
Bioengineered|October 26, 2021
Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsiaZhenjing Chi, Yanlan Sun, Zhou Yu, et al.
Critical Reviews in Eukaryotic Gene Expression|August 23, 2022
Downregulation of microRNA-342-3p Eases Insulin Resistance and Liver Gluconeogenesis via Regulating Rfx3 in Gestational Diabetes MellitusYanlan Sun, Zhou Yu, Yulei Zhang, et al.
Environmental Toxicology|April 28, 2021
LINC00473 downregulation facilitates trophoblast cell migration and invasion via the miR-15a-5p/LITAF axis in pre-eclampsiaZhenjing Chi, Qiong Gao, Yanlan Sun, et al.
Drug Delivery|March 21, 2022
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD miceRuifeng Mao, Menglan Yang, Rui Yang, et al.
Drug Delivery|January 31, 2023
Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD miceRuifeng Mao, Jin Wang, Ying Xu, et al.
Pageof 1